MedTrace Logo

MinSafeStart - Decision Aid Tool for Better Treatment of Nausea and Vomiting During Pregnancy

NCT04719286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 217

Last updated 2023-11-28

No results posted yet for this study

Summary

Nausea and vomiting in pregnancy (NVP) is affecting up to 70% of pregnant women. Studies have also shown that NVP may have a profound impact on pregnant women's wellbeing and that even mild NVP symptoms have been shown to significantly reduce pregnant women's quality of life. However, NVP symptoms often occur during the first period of pregnancy where antenatal care not yet have been established.

The objective of this project is to evaluate whether the "MinSafeStart" mobile application (app) can empower pregnant women to better self-manage NVP and hence improve their quality of life.

Conditions

  • Hyperemesis Gravidarum
  • Emesis
  • Emesis Pregnancy

Interventions

DEVICE

MinSafeStart app

The intervention is the opportunity of using the MinSafeStart app. Women can register their NVP severity in the app by answering a few questions daily. Based on this, they will get tailored advice on NVP, and get alert when they should see a doctor.

Sponsors & Collaborators

  • Hedvig Marie Egeland Nordeng

    lead OTHER

Principal Investigators

  • Henrik Schultz, MSc · Department of Pharmacy, University of Oslo

  • Hedvig Nordeng · Department of Pharmacy, University of Oslo

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-02
Primary Completion
2020-07-01
Completion
2022-05-16

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04719286 on ClinicalTrials.gov